Nov 20, 2017 — Dr. Watts has held a number of clinical and administrative leadership positions at two renowned academic medical centers, Northwestern (Feinberg School of Medicine, Northwestern Memorial Hospital) and the University of Michigan, and with his training and extensive clinical career as a Pulmonary-Critical Care specialist, he adds a comprehensive background of clinical practice and healthcare administration to […]
New from LabRoots: Dr. Margie Morgan to present on the impact of fast phenotypic susceptibility results to laboratory workflow and patient outcomes
Nov 09, 2017 — Dr. Margie Morgan, Scientific Director Microbiology at Cedars-Sinai Medical Center, is scheduled to present on the impact that fast phenotypic antibiotic susceptibility results have to laboratory workflow and patient outcomes at the LabRoots Clinical Diagnostics and Research Virtual Event, November 9th at 12:30 p.m. ET.
Accelerate Diagnostics reports Q3 2017 financial results
Nov 02, 2017 — Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending September 30, 2017. The company further reported signed agreements for 295 instruments year to date; contracts for customer evaluations total 239 instruments while revenue generating placements grew to 56 across the U.S., European, and Middle East regions.
Third Quarter 2017 Conference Call Set for November 2nd
Oct 17, 2017 — Accelerate Diagnostics, Inc. will announce third quarter 2017 financial results at the close of U.S. financial markets on Thursday, November 2, 2017.
See all news
Enter your email address below for access to photos, logos and videos.
Connect with us
February 25-28, 2018
San Antonio, TX
18-19 Décembre 2017
Palais des Congrès de Paris
Stay up to date with Accelerate by joining our mailing list.Sign up today
October 4–8, 2017
June 1–5, 2017
May 10–13, 2017
April 22–25, 2017
March 26–28, 2017
March 21–27, 2017
11 au 13 Janvier 2017
Porte de Versailles a Paris
12-13 Décembre 2016
Palais des Congrès de Paris
November 3-5, 2016
October 26–30, 2016
September 7–10, 2016
Fort Worth, TX
June 16–20, 2016
April 9–12, 2016
Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.
Automated microscopy for rapid directed antibiotic treatment of sepsis
M Kollef, C Burnham, B Fuller
Washington University School of Medicine
Evaluation of the Accelerate Pheno™ system for fast identification and antimicrobial susceptibility testing from positive blood culture in Gram-negative bloodstream infection
Matthias Marschal, Johanna Bachmaier, Ingo Autenrieth, Philipp Oberhettinger, Matthias Willmann and Silke Peter
University of Tübingen
Evaluation of Accelerate Pheno™ System in a Clinical Setting: Comparison of Identification and Antibiotic Susceptibility Test Results of 224 Prospective Positive Blood Cultures to Standard Laboratory Methods at Detroit Medical Center
Learn about ourTechnology